These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22269860)

  • 1. Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities.
    Scaglione F; Berrino L
    Int J Antimicrob Agents; 2012 Jun; 39(6):458-63. PubMed ID: 22269860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine.
    Borroto-Esoda K; Parkin N; Miller MD
    Antivir Chem Chemother; 2007; 18(5):297-300. PubMed ID: 18046962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
    Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
    J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-HIV activities of symmetrical dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
    Agarwal HK; Buckheit KW; Buckheit RW; Parang K
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5451-4. PubMed ID: 22858097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
    Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
    J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine.
    Gao WY; Johns DG; Mitsuya H
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):371-7. PubMed ID: 10772721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine.
    Feng JY; Myrick FT; Margot NA; Mulamba GB; Rimsky L; Borroto-Esoda K; Selmi B; Canard B
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):89-107. PubMed ID: 16440988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria.
    Morris GW; Laclair DD; McKee EE
    Antivir Ther; 2010; 15(4):587-97. PubMed ID: 20587852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
    Otto MJ
    Curr Opin Pharmacol; 2004 Oct; 4(5):431-6. PubMed ID: 15351346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological properties and anti-HIV-1 activity of new pyrimidine P1,P2-dinucleotides.
    Miazga A; Ziemkowski P; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):438-44. PubMed ID: 20544533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
    Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
    AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine.
    Cahn P; Wainberg MA
    J Antimicrob Chemother; 2010 Feb; 65(2):213-7. PubMed ID: 20007333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
    Marcelin AG; Charpentier C; Wirden M; Landman R; Valantin MA; Simon A; Katlama C; Yeni P; Descamps D; Aubron-Olivier C; Calvez V
    J Antimicrob Chemother; 2012 Jun; 67(6):1475-8. PubMed ID: 22371439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
    Miller V; Larder BA
    Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The M184V mutation: what it does, how to prevent it, and what to do with it when it's there.
    Gallant JE
    AIDS Read; 2006 Oct; 16(10):556-9. PubMed ID: 17096474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.
    Siddiqui MA; Hughes SH; Boyer PL; Mitsuya H; Van QN; George C; Sarafinanos SG; Marquez VE
    J Med Chem; 2004 Oct; 47(21):5041-8. PubMed ID: 15456247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors.
    Agarwal HK; Chhikara BS; Doncel GF; Parang K
    Bioorg Med Chem Lett; 2017 May; 27(9):1934-1937. PubMed ID: 28351588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Ma XD; Zhang X; Dai HF; Yang SQ; Yang LM; Gu SX; Zheng YT; He QQ; Chen FE
    Bioorg Med Chem; 2011 Aug; 19(15):4601-7. PubMed ID: 21719299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases: implications for human immunodeficiency virus drug design.
    Kukhanova M; Li X; Chen SH; King I; Doyle T; Prusoff W; Cheng YC
    Mol Pharmacol; 1998 May; 53(5):801-7. PubMed ID: 9584205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.